Average Co-Inventor Count = 6.72
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (6 from 3,923 patents)
2. Selux Diagnostics, Inc. (4 from 19 patents)
3. Harvard College (3 from 2,961 patents)
13 patents:
1. 12209144 - Cyclic peptides as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
2. 11813306 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
3. 11427586 - 1,2,4-oxadiazole derivatives as liver X receptor agonists
4. 11026993 - Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders
5. 10982254 - Methods for rapid antimicrobial susceptibility testing
6. 10501772 - Methods for rapid antimicrobial susceptibility testing
7. 10202400 - Cortistatin analogues and syntheses thereof
8. 10048269 - Assay methods involving dissociable nanoparticles
9. 9834808 - Methods for rapid antibiotic susceptibility testing
10. 9714255 - Cortistatin analogues and syntheses thereof
11. 9505755 - Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators
12. 9127019 - Cortistatin analogues and synthesis thereof
13. 8846656 - Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators